The TBPod
The TBPod is a podcast for clinicians and policymakers caring for patients with tuberculosis. The podcasts present discussions with expert clinicians, researchers, policymakers and advocates about their work in the field of tuberculosis. Tuberculosis remains one of the leading causes of death worldwide, and is an important contributor to morbidity among migrants arriving in Australia and New Zealand. There are around 1300 reported cases of TB in Australia each year, and a further 300 in New Zealand. Included in these figures are cases of multi-drug resistant (MDR) TB which pose significant barriers to treatment and management of the disease. The Australian government has committed to the global elimination of TB by 2030, but to do so requires the development of innovative new strategies, based on high-quality research, that has national and international reach. These podcasts aim to engage and update those who are interested in the field of tuberculosis through discussions with leaders in the field of tuberculosis.
Episodes
38 episodes
Tuberculosis Trailblazers: Nurses Leading the Fight with Amanda Christensen
Amanda Christensen joins us in this month's edition to discuss the critical impact of nurses in the fight against tuberculosis. Amanda is the Executive Director at the Australian Respiratory Council and is deeply experienced in the field...
•
24:57
Advancing TB Care: The Statistical Design of Clinical Trials with Patrick Phillips
Today we had the pleasure of being joined by Associate Professor Patrick Phillips from the University of California, who is the Co-Director of the UC Tuberculosis Research Advancement Center, Clinical & Population Health Science Core. Patri...
•
36:05
The Trauma of TB Stigma - Lived Experiences with Handaa Enkh Amgalan
Handaa Enkh Amgalan is an author, TB advocate and director of QA at the International Rescue Committee in Germany who has not only recently spoken at the UN TB High Level Meeting but also written an incredible memoir of her experience being dia...
•
29:19
Frontiers in Clinical Tuberculosis Microbiology - New TBI Diagnostics with Prof Martineau
Professor Adrian Martineau from the Queen Mary University London talks to us about the limitations of current latent TB infection diagnosis and how we can do better. his research into whether we can use fragments of TB DNA found in bone m...
•
30:08
MTBVAC - one of the most promising new TB Vaccines with Dr Carlos Martín Montañés
Today we discuss the MTBVAC with Dr Montañés. MTBVAC is an attenuated vaccine from a human mycobacterial isolate which has just progressed to a phase 3 trial and shown very promising results in the phase 2 study. Dr Montañés has been involved i...
•
42:58
TB Contact Tracing and Building Research in TB with Prof Philip Hill
Prof Greg Fox speaks with Prof Philip Hill about TB household contact tracing and building research capacity in TB. Prof Hill is an ID specialist and public health physician who did his PhD in TB Epidemiology. He is the current McAuley ...
•
30:13
END-TB Trial with Dr Guglielmetti
Today we speak with Dr Guglielmetti about the END-TB trial which looks at new all oral regimens for MDR-TB.REFERENCES1) https://endtb.org/2) Nyang’wa, Bern-Thomas, et al. "A 24-week, all-oral regimen for rifampin-resistant tuber...
•
46:27
Tuberculosis Diagnostics & Emerging Technologies with Dr Morten Ruhwald
Today we delve into the world of TB diagnostics and the future of leveraged TB technologies with Dr Morten Ruhwald. Dr Ruhwald is a the head of the TB programme over at FIND, an institution dedicated to accelerating equitable access to reliable...
•
24:14
Tuberculosis Nursing Challenges in Australia's Northern Territory with Dr Chris Lowbridge
Today we speak with Dr Chris Lowbridge about the amazing work of the TB teams in the Northern Territory. Chris talks about the challenges of controlling tuberculosis across 1.42 million square kilometres, more than 100 local languages, and some...
•
36:21
Drug Development with Dr Clifton Barry
Today we speak with Dr Clifton Barry from NIH in Bethesda, Maryland who is head of the most highly cited research group in the field of TB over the past year and has made extraordinary contributions to TB drug development. Dr Barry speaks about...
•
42:02
Where are we with TB Vaccines - with Prof Triccas
Today we get an update on where the TB Vaccine pipeline is up to, how TB vaccines work and what exciting candidates might be on the horizon. We speak with Professor Jamie Triccas from the University of Sydney about his work as the principal inv...
•
40:33
What does TB Elimination mean?
Today we have the pleasure of speaking with Professor Giovanni Migliori about TB Elimination. Professor Migliori is the director of the WHO collaborating centre for TB and lung disease and is the current chief editor for the international journ...
•
40:43
Papua New Guinean Challenges of TB in Pregnancy
Today we speak with Prof Mola, Dr Welch and Dr Visiliu about their amazing work tackling TB in pregnancy in Papua New Guinea. They talk about the epidemiological, geographical and social challenges of providing maternal TB care in PNG along wit...
•
34:15
How WGS is shaping the public health in Australia
Today we speak with Professor Justin Denholm about his work with the National TB Advisory Committee in Australia and the role whole genome sequencing (WGS) has in public health. Professor Denholm talks about how WGS is expanding the way we thin...
•
40:32
Discovery of tuberculosis - the life of Robert Koch
In this extraordinary episode we speak with renowned historian Professor Christoph Gradmann about the life and work of German physician Robert Koch. In this episode we look at how Koch came to discover tuberculosis and what it meant for the fie...
•
48:22
Differentiating TB from Sarcoid
Today we have the pleasure of speaking to both Professor Leonard (Respiratory physician and director of the sarcoidosis service for Manchester Foundation Trust) and Dr Montero (director of cellular pathology for Wythenshawe Hospital) about the ...
•
32:03
Mind the Gap - Update on Global TB Goals
Today I had the privilege of speak with Professor Christoph Lange, Secretary General of the Union, founding chairman of TBNet and is the clinical lead for the Unite4TB Consortium. Professor Lange spoke to us about where we're up to with our End...
•
45:13
Understanding TB Diagnostic Tests
Today I had the pleasure of speaking with Dr Emily MacLean about the exciting modern tests both commercially available and in research development for diagnosing tuberculosis. Emily talked to us about how GeneXpert has evolved and how we can ge...
•
40:07
Understanding TB Screening Tests
Today I had the pleasure of speaking with Dr Geoff Eather from the Princess Alexandra Hospital in Brisbane about his work and research on TST and IGRA screening for tuberculosis. This was a fantastic experience to learn more about these incredi...
•
32:50
Tuberculosis Modelling
Today I had the pleasure of speaking to Hojoon Sohn, an associate professor in infectious disease epidemiologist at the Seoul National University College of Medicine. Hojoon is an expert in TB modelling and speaks to us about his research in de...
•
30:39
Therapeutic Drug Monitoring in TB
Today we speak to Professor Jan-Willem Alffenaar from Westmead Hospital and the University of Sydney about Therapeutic Drug Monitoring in Tuberculosis. Professor Alffenaar reviews the PK/PD issues with common TB medications, the strengths and w...
•
33:48
Predicting Side Effects in 3HP
Today we speak with Professor Jann-Yuan Wang, a clinician and researcher in Taiwan, about his work in latent tuberculosis. Professor Wang speaks about his experience using 3HP and the challenges of systemic drug reactions. Professor Wang talks ...
•
18:09
Treatment of Drug Resistant TB
Drug Resistant TB is a growing problem with some exciting advances over the past decade. With the recent Rapid Communication from the WHO and the advent of the B-PALMS regimen, drug resistant TB is a changing and exciting field of tuberculosis ...
•
34:09